Phathom Pharmaceuticals, Inc. PHAT Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s shares (diluted)?
- Phathom Pharmaceuticals, Inc. (PHAT) reported shares (diluted) of 82.1M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s shares (diluted) changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s shares (diluted) increased by 14.0% year-over-year, from 72M to 82.1M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s shares (diluted) has grown at a 18.5% compound annual growth rate (CAGR), from 147.2M to 290.8M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.